Understanding how protein modifications help human cells respond to stress

Characterizing new redox roles for protein ubiquitination in human cells

NIH-funded research Duke University · NIH-10371928

This study looks at how our cells handle stress from things like UV rays and pollution, focusing on a special protein called ubiquitin that helps control other proteins during tough times, with the goal of finding ways to help cells stay strong and healthy.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionDuke University NIH-funded
Lab location1 site (Durham, United States)
Project IDNIH-10371928 on NIH RePORTER

What this research studies

This research investigates how human cells manage oxidative stress caused by environmental factors like UV radiation and pollutants. It focuses on the role of ubiquitin, a protein that modifies other proteins to control their function and fate, particularly during stress responses. The study aims to uncover the mechanisms by which ubiquitin helps cells survive under stress by regulating protein production and degradation. By examining the specific ubiquitin enzymes involved, the research seeks to provide insights into cellular resilience and potential therapeutic targets.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with conditions related to oxidative stress, such as cancer or chronic diseases.

Not a fit: Patients with acute conditions unrelated to oxidative stress may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for enhancing cellular resilience against stress, potentially benefiting patients with chronic diseases or cancers.

How similar studies have performed: Other research has shown promising results in understanding the role of ubiquitin in stress responses, indicating that this approach has potential for significant findings.

Where this research is happening

Durham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Cancersneoplasm/cancer
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.